[PAH in congenital heart defects--therapeutic experiences with children and adults].
Schulze-Neick
Ingram
I
Deutsches Herzzentrum Berlin, Klinik für angeborene Herzfehler/Kinderkardiologie, Berlin.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D002648:Child; D002986:Clinical Trials as Topic; D065128:Endothelin Receptor Antagonists; D006330:Heart Defects, Congenital / Q000235:genetics / Q000451:nursing*; D006343:Heart Septal Defects / Q000188:drug therapy / Q000451:nursing; D006801:Humans; D006976:Hypertension, Pulmonary / Q000235:genetics / Q000451:nursing*; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome; D014655:Vascular Resistance / Q000187:drug effects* / Q000235:genetics
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan